期刊
JOURNAL OF NEUROCHEMISTRY
卷 139, 期 -, 页码 200-214出版社
WILEY
DOI: 10.1111/jnc.13592
关键词
Alzheimer's disease; AMPAR trafficking; ERK1; 2; Fragile X syndrome; mGluR-LTD; p38 mitogen-activated protein kinase
资金
- Wellcome Trust [200646/Z/16/Z] Funding Source: Wellcome Trust
- BBSRC [BB/H018344/1, BB/K019899/1] Funding Source: UKRI
- MRC [MR/K023098/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/H018344/1, BB/K019899/1] Funding Source: Medline
- Medical Research Council [MR/K023098/1] Funding Source: Medline
- Wellcome Trust [200646/Z/16/Z] Funding Source: Medline
- Biotechnology and Biological Sciences Research Council [BB/K019899/1, BB/H018344/1] Funding Source: researchfish
- Medical Research Council [MR/K023098/1] Funding Source: researchfish
Group I metabotropic glutamate receptor (mGluR) dependent long-term depression (LTD) is a major form of synaptic plasticity underlying learning and memory. The molecular mechanisms involved in mGluR-LTD have been investigated intensively for the last two decades. In this 60th anniversary special issue article, we review the recent advances in determining the mechanisms that regulate the induction, transduction and expression of mGluR-LTD in the hippocampus, with a focus on the mitogen-activated protein kinase (MAPK) pathways. In particular we discuss the requirement of p38 MAPK and extracellular signal-regulated kinase 1/2 (ERK 1/2) activation. The recent advances in understanding the signaling cascades regulating mGluR-LTD are then related to the cognitive impairments observed in neurological disorders, such as fragile X syndrome and Alzheimer's disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据